"GSK pumps up to $800m for US manufacturing site upgrade" was originally created and published by Pharmaceutical Technology, ...
GSK has made another investment in its manufacturing network, setting aside $800 million to build two plants at its Marietta site in the US. The programme represents the largest capital spend by ...
For GSK’s Ramakrishnan, who has served as CDTO since 2021, the biggest challenge was helping her company get a head start in ...
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
SINGAPORE - The expansion of British drugmaker GSK’s facility in Tuas has earned ... an affiliate of German biotech company BioNTech acquired a manufacturing site from Novartis Singapore to ...